|
[1]
|
王彦. 多倍体细胞与肿瘤关系的研究进展[J]. 国际妇产科学杂志, 2010, 37(6): 420-422.
|
|
[2]
|
Tse, C.H., Hwang, H.C., Goldstein, L.C., Kandalaft, P.L., Wiley, J.C., Kussick, S.J. and Gown, A.M. (2011) Determining True HER2 Gene Status in Breast Cancers with Polysomy by Using Alternative Chromosome 17 Reference Genes: Implications for Anti-HER2 Targeted Therapy. Journal of Clinical Oncology, 29, 4168-4174.
https://doi.org/10.1200/JCO.2011.36.0107
|
|
[3]
|
Tibau, A., López-Vilaró, L., Pérez-Olabarria, M., Vázquez, T., Pons, C., Gich, I., et al. (2014) Chromosome 17 Centromere Duplication and Responsiveness to Anthracycline-Based Neoadjuvant Chemotherapy in Breast Cancer. Neoplasia, 16, 861-867.
https://doi.org/10.1016/j.neo.2014.08.012
|
|
[4]
|
Afify, A. and Mark, H.F.L. (1997) Fluorescence in Situ Hybridization Assessment of Chromosome 8 Copy Number in Stage I and Stage II Infiltrating Ductal Carcinoma of the Breast. Cancer Genetics and Cytogenetics, 97, 101-105.
https://doi.org/10.1016/S0165-4608(96)00361-5
|
|
[5]
|
Watters, A.D., Going, J.J., Cooke, T.G. and Bartlett, J.M.S. (2003) Chromosome 17 Aneusomy Is Associated with Poor Prognostic Factors in Invasive Breast Carcinoma. Breast Cancer Re-search and Treatment, 77, 109-114.
https://doi.org/10.1016/j.neo.2014.08.012
|
|
[6]
|
Krishnamurti, U., Hammers, J.L., Atem, F.D., Storto, P.D. and Silverman, J.F. (2009) Poor Prognostic Significance of Unamplified Chromosome 17 Polysomy in Invasive Breast Carcinoma. Modern Pathology, 22, 1044-1048.
https://doi.org/10.1038/modpathol.2009.61
|
|
[7]
|
Pritchard, K.I., Munro, A., O’Malley, F.P., Tu, D.S., Li, X., Levine, M.N., et al. (2012) Chromosome 17 Centromere (CEP17) Duplication as a Predictor of Anthracycline Response: Evidence from the NCIC Clinical Trials Group (NCLC CTG) MA.5 Trial. Breast Cancer Research and Treatment, 131, 541-551.
https://doi.org/10.1007/s10549-011-1840-4
|
|
[8]
|
Bartlett, J.M., Munro, A.F., Dunn, J.A., McConkey, C., Jordan, S., Twelves, C.J., et al. (2010) Predictive Markers of Anthracycline Benefit: A Prospectively Planned Analysis of the UK National Epirubicin Adjuvant Trial (NEAT/ BR9601). The Lancet Oncology, 11, 266-274.
https://doi.org/10.1016/S1470-2045(10)70006-1
|
|
[9]
|
李璐. 肺癌染色体非整倍体的间期核荧光原位杂交研究[D]: [博士学位论文]. 北京: 中国协和医科大学, 2007.
|
|
[10]
|
Kubokura H., et al. (2001) Relations of the c-myc Gene and Chromosome 8 in Non-Small Cell Lung Cancer: Analysis by Fluorescence in Situ Hybridization. Annals of Thoracic and Cardiovascular Surgery, 7, 197-203.
|
|
[11]
|
Yakut, T., Egeli, U. and Gebitekin, C. (2003) Investigation of c-Myc and p53 Gene Alterations in the Tumor and Surgical Borderline Tissues of NSCLC and Effects on Clinicopathologic Behavior: By the FISH Technique. Lung, 181, 245-258.
https://doi.org/10.1007/s00408-003-1026-x
|
|
[12]
|
Chen, Y.Y. and Xu, G. (2014) Effect of Circulating Tumor Cells Combined with Negative Enrichment and CD45-FISH Identification in Diagnosis, Therapy Monitoring and Prognosis of Primary Lung Cancer. Medical Oncology, 31, 240.
https://doi.org/10.1007/s12032-014-0240-0
|
|
[13]
|
Wilkens, L., et al. (2001) Diagnostic Impact of Fluorescence in Situ Hybridization in the Differentiation of Hepatocellular Adenoma and Well-Differentiated Hepatocellular Carcinoma. Journal of Molecular Diagnostics, 3, 68-73.
https://doi.org/10.1016/S1525-1578(10)60654-X
|
|
[14]
|
Nasarek, A., Werner, M., Nolte, M., Georgii, A. and Klempnauer, J. (1995) Trisomy 1 and 8 Occur Frequently in Hepatocellular Carcinoma but Not in Liver Cell Adenoma and Focal Nodu-larhyperplasis. A Fluorescence in Situ Hybridization Study. Virchows Archiv, 427, 373-378.
https://doi.org/10.1007/BF00199385
|
|
[15]
|
Wilkens, L., et al. (2004) Induction of Aneuploidy by Increasing Chromo-somal Instability during Dedifferentiation of Hepatocellular Carcinoma. Proceedings of the National Academy of Sciences of the United States of America, 101, 1309-1314.
https://doi.org/10.1073/pnas.0305817101
|
|
[16]
|
Sayagués, J.M., et al. (2010) Intratumoural Cytogenetic Heterogeneity of Sporadic Colorectal Carcinomas Suggests Several Pathways to Liver Metastasis. Journal of Pathology, 221, 308-319.
https://doi.org/10.1002/path.2712
|
|
[17]
|
Galimi, F., et al. (2011) Genetic and Expression Analysis of MET, MACC1, and HGFin Metastatic Colorectal Cancer: Response to Met Inhibitionin Patient Xenografts and Pathologic Correlations. Clinical Cancer Research, 17, 3146- 3156.
https://doi.org/10.1158/1078-0432.CCR-10-3377
|
|
[18]
|
Hu, J., Khanna, V., Jones, M.M.W. and Surti, U. (2002) Genomic Imbalances in Ovarian Borderline Serous and Mucinous Tumors. Cancer Genetics and Cytogenetics, 139, 18-23.
https://doi.org/10.1016/S0165-4608(02)00603-9
|
|
[19]
|
Darcy, K.M., et al. (2009) Prognostic Relevance of c-MYC Gene Amplification and Polysomy for Chromosome 8 in Suboptimally-Resected, Advanced Stage Epithelial Ovarian Cancers: A Gynecologic Oncology Group Study. Gynecologic Oncology, 114, 472-479.
https://doi.org/10.1016/j.ygyno.2009.05.012
|
|
[20]
|
Ning, N., et al. (2014) Improvement of Specific Detection of Circu-lating Tumor Cells Using Combined CD45 Staining and Fluorescence in Situ Hybridization. Clinica Chimica Acta, 433, 69-75.
https://doi.org/10.1016/j.cca.2014.02.019
|
|
[21]
|
Zojer, N., et al. (1998) Chromosomal Imbalances in Primary and Metastatic Pancreatic Carcinoma as Detected by Interphase Cytogenetics: Basic Findings and Clinical Aspects. British Journal of Cancer, 77, 1337-1342.
https://doi.org/10.1038/bjc.1998.223
|
|
[22]
|
Schleger, C., Verbeke, C., Hildenbrand, R., Zentgraf, H. and Bley, U. (2002) C-MYC Activation in Primary and Metastatic Ductal Adenocarcinoma of the Pancreas: Incidence, Mechanisms, and Clinical Significance. Modern Pathology, 15, 462-469.
https://doi.org/10.1038/modpathol.3880547
|
|
[23]
|
Zhang, Y., et al. (2015) Patterns of Circulating Tumor Cells Identified by CEP8, CK and CD45 in Pancreatic Cancer. International Journal of Cancer, 136, 1228-1233.
https://doi.org/10.1002/ijc.29070
|
|
[24]
|
Ciesielski, M., et al. (2014) The HER2 Gene and HER2 Protein Status and Chromosome 17 Polysomy in Gastric Cancer Cells in Own Material. Applied Immunohistochemistry & Molecular Morphology, 23, 113-117.
https://doi.org/10.1097/PAI.0000000000000070
|
|
[25]
|
Li, Y., et al. (2014) Clinical Significance of Phenotyping and Karyotyping of Circulating Tumor Cells in Patients with Advanced Gastric Cancer. Oncotarget, 5, 6594-6602.
https://doi.org/10.18632/oncotarget.2175
|